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Introduction: Adrenal dysfunction may represent critical illness-related corticosteroid insufficiency (CIRCI), as evidenced
by a diminished cortisol response to exogenous adrenocorticotropic hormone (ACTH), but this concept and its clinical
significance remain highly controversial. We studied the adrenal response to exogenous ACTH as a function of
the endogenous cortisol-to-ACTH ratio, a measure of adrenal sensitivity, and of clinical variables, during critical
illness and recovery from the acute phase.
Methods: We prospectively included 59 consecutive septic and nonseptic patients in the intensive care unit
with treatment-insensitive hypotension in whom CIRCI was suspected; patients having received etomidate and
prolonged corticosteroids were excluded. An ACTH test (250 μg) was performed, followed by a second test
after ≥7 days in acute-phase survivors. Serum total and free cortisol, ACTH, and clinical variables were assessed.
Patients were divided according to responses (delta, Δ) of cortisol to ACTH at the first and second tests.
Results: Patients with low (<250 nM) Δ cortisol (n = 14 to 17) had higher baseline cortisol and ACTH but lower
cortisol/ACTH ratios than patients with a normal Δ cortisol (≥250 nM) in the course of time. A low Δ cortisol in
time was associated with more-severe disease, culture-positive sepsis, and prolonged activated prothrombin
time. Results for free cortisol were similar.
Conclusions: Even though the pituitary-adrenal axis is activated after stress during critical illness, diminished
adrenal sensitivity to endogenous ACTH predicts a low increase of cortisol to exogenous ACTH, suggesting
adrenal dysfunction, irrespective of the stage of disease. The data further suggest a role of disease severity and
culture-positive sepsis.Introduction
The stress of critical illness, and sepsis in particular,
strongly activates the hypothalamic-pituitary-adrenal
(HPA) axis and increases circulating cortisol [1-9]. Never-
theless, the secretion and concentration of (free) cortisol
may be relatively insufficient, even when not subnormal,
for the severity of disease in the course of critical illness-
related corticosteroid insufficiency (CIRCI), which may
relate to morbidity and mortality, particularly in sepsis
[2,3,6-15]. Albeit hotly debated, a relatively low increase
in circulating cortisol on exogenous adrenocorticotro-
pic hormone (ACTH) stimulation may denote adrenal* Correspondence: mfc.dejong@gmail.com
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unless otherwise stated.dysfunction, which is associated with severe disease and
ultimate mortality, and may warrant treatment with
corticosteroids to increase survival from septic shock
[2,6,7,11,12,14]. This may be accompanied by relatively
high baseline cortisol levels but, as some studies suggest,
by low cortisol/ACTH ratios, indicative of diminished ad-
renal sensitivity, even when ACTH levels do not exceed
normal values [3,4,6,7,16-18]. Treatment with etomidate-
inhibiting adrenal cortisol synthesis, indeed, reduces the
cortisol/ACTH ratio and diminishes the cortisol response
to exogenous ACTH [16,19]. The ratio is used to diag-
nose primary absolute adrenal insufficiency [20]. How-
ever, Boonen et al. [21] recently suggested that, during
critical illness, impaired cortisol metabolism (measured
in relatively few patients) contributes to elevated (free)
cortisol levels and low endogenous ACTH levels vial. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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to exogenous ACTH in the absence of adrenal dysfunc-
tion. A diminished response to exogenous ACTH is, how-
ever, hard to explain on the basis of an acutely low
endogenous ACTH level only. Nevertheless, decreased
metabolism might explain in part the dissociation between
low ACTH and elevated cortisol concentrations in persist-
ent rather than acute (as in the Boonen et al. study [21])
critical illness over days, attributed to hypersensitivity or
non-ACTH stimulation of the adrenals [6,22,23]. The con-
troversy on adrenal function in critical illness is further
compounded by the allegedly poor relation between
protein-bound total and free cortisol involved in tis-
sue effects and feedback, but increases in free cortisol may
parallel increases in total cortisol, irrespective of binding
proteins [5,17].
Finally, the question remains whether adrenal injury
contributes to dysfunction, for instance, after diffuse
intravascular coagulation and adrenal thrombosis or
hemorrhage, as may occur during meningococcemia,
other causes of sepsis, and heparin treatment, among
others [2,16,24,25]. We previously showed in transversal
but also in longitudinal, retrospectively analyzed observa-
tions that clinical predictors for a diminished cortisol re-
sponse to exogenous ACTH are septic shock with severe
disease, acidosis, and organ failure on the one hand and
coagulation disturbances on the other [8,15]. In any case,
a relatively low exogenous ACTH response during critical
illness may normalize when disease severity resolves in
surviving patients, whereas a decrease in response may be
associated with increasing severity of disease and mortality,
arguing against the ACTH test as a poorly reproducible la-
boratory phenomenon in the critically ill [15,26-28]. This
may favor reversal and development of adrenal dysfunction
in time, respectively.
The hypothesis for the present study is, first, that di-
minished adrenal sensitivity to endogenous ACTH at-
tenuates responses to exogenous ACTH, irrespective of
the stage of critical illness. Second, these abnormalities
characterize adrenal dysfunction and insufficiency rela-
tive to disease severity in the course of critical illness.
Third, sepsis and its sequelae is a main risk factor for
adrenal dysfunction. We therefore examined these fac-
tors longitudinally in a cohort of critically ill patients
who were able to undergo repeated ACTH testing.
Materials and methods
Patient population and ACTH test
This prospective study was carried out in the 32-bed
general intensive care unit (ICU) of a university hospital
from December 2004 to March 2007. According to
Dutch legislation and the institutional ethical committee
(Medical Ethical Committee VUmc, chair Prof dr JA
Rauwerda), we did not need ethical approval and informedconsent, because the ACTH test is routinely performed in
our department for patient care, when clinically indicated,
no extra blood was drawn for this study, and the results
were treated anonymously. In the study period, an ACTH
test was performed in 288 consecutive patients, and 59 pa-
tients (20%) were included when fulfilling criteria for the
current study (Figure 1). These patients were older than
18 years, with a clinical suspicion of CIRCI on the basis
of >6-hour hypotension (<100 mm Hg systolic) requiring
repeated fluid challenges and/or vasopressor/inotropic
treatment. They underwent a first ACTH test in the ICU
(Test 1) and a second test (Test 2) before or after discharge
from the ICU. A minimum interval of 7 days occurred be-
tween tests and a minimum interval of 5 days after cessa-
tion of hydrocortisone treatment when started. Patients
were excluded if they had a history of HPA disease, if they
received glucocorticoid treatment within 3 months of Test
1, or if they received etomidate before endotracheal intub-
ation, because etomidate is a well-known inhibitor of ad-
renal function [2,13,14,16].
All patients underwent a short 250-μg ACTH (tetraco-
sactide-hexa-acetate, Synacthen, Novartis Pharma, Basel,
Switzerland) test. Blood samples were taken at baseline
and 30 and 60 minutes after intravenous injection. Serum
total cortisol was measured with competitive immunoassay
(Advia Centaur; Siemens Diagnostics, Deerfield, IL, USA).
The intra- and interassay coefficients of variation were 3%
and 6%, respectively, and the detection limit was 30 nM
(500 nM = 18 μg/dl). Serum free cortisol levels were
measured with equilibrium dialysis of undiluted serum
samples (n = 49 available) followed by radioimmuno-
assay (Orion Diagnostica, Espoo, Finland; <6% crossreac-
tivity with cortisone). The intra- and interassay coefficients
of variation were less than 7% and 8%, respectively. Sam-
ples for ACTH were immediately put on ice, and ACTH
was determined with an immunometric assay and CBG
with radioimmunoassay (Immulite 2500; Siemens Medical
Diagnostic Solutions; n ACTH 2 to 26 pM; and BioSource,
Nivelles, Belgium; n 30–54 mg/L, respectively). We calcu-
lated the ratio of baseline cortisol/ACTH as a param-
eter of adrenal sensitivity [3,4,16-18]. The peak (at 30
or 60 minutes) minus baseline cortisol level was taken to
calculate increases on exogenous ACTH. A low response
to ACTH in critical illness was defined by a subnormal
total cortisol increase (<250 nmol/L) [6,7,10,12-14].
Data collection
At study entry, the following parameters were recorded:
time from ICU admission, age and sex, and ICD-10
diagnoses of common clinical conditions at admission.
At the day of each ACTH test, the following were col-
lected: serum total and free cortisol levels before and 30
and 60 minutes after 250 μg of i.v. ACTH, serum levels
of ACTH cortisol-binding globulin (CBG), and albumin.
Figure 1 Flow chart of patient inclusion for this study.
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cell count, platelet count, activated partial thrombo-
plastin time (aPTT), and prothrombin time (PT). In-
terventions including type and doses of vasopressor/
inotropes, intubation, need for mechanical ventila-
tion, and renal replacement therapy were recorded.
Sepsis was defined as the presence of systemic in-
flammatory response syndrome (SIRS) with a positive
microbiologic local (urine, trachea, or other) and/or
blood culture. SIRS was defined as two or more of the
following criteria: a temperature of >38°C or <35.5°C, a
leukocyte count >12 of <4 × 109/L, a heart rate >90 per
minute, and a respiratory rate >20 per minute, or the
presence of mechanical ventilation. Suspected or micro-
biologically proven sources of sepsis were recorded. Dis-
ease severity was assessed by the acute physiology and
chronic health evaluation score (APACHE II) and sequen-
tial organ-failure assessment score (SOFA) on the days of
the ACTH test, and length of ICU stay and mortality in
the ICU and hospital were recorded.
Clinical management
Patients were treated according to local protocols, de-
rived from national and international guidelines. Treat-
ment of sepsis included antibiotics and drainage, whenever
possible, and intubation, mechanical ventilation, and con-
tinuous veno-venous hemofiltration (CVVH) were insti-
tuted when needed. Patients and caregivers were not
blinded to ACTH test results and moderate dose cortico-
steroids (hydrocortisone starting 100 mg TID i.v.) was ad-
ministered at the discretion of attending intensivists. Foranticoagulation, for instance during CVVH, mostly heparin
was used.
Statistical analysis
For categoric data the χ2 and Fisher Exact test were used
(SPSS v21; IBM SPSS Inc, Chicago, IL, USA). Con-
tinuous variables were tested for normality with the
Kolmogorov-Smirnov test, and if P < 0.05, they were
logarithmically transformed for further analysis with
the help of generalized estimating equations (GEEs).
This was performed to investigate the association of
Δ cortisol, time, and their first-order interaction to
endocrine and clinical variables (in a linear model),
taking repeated measurements in the same patients
into account (in an exchangeable matrix). The Mann–
Whitney U test was done for other group compari-
sons. The Spearman correlation coefficient (rs) was
used to express the relation between pooled variables.
Receiver operating characteristic area under the curve
(AUROC) was used to evaluate predictive values. A
two-sided P < 0.05 was considered to indicate statis-
tical significance, and exact P values are given, unless




Patient characteristics are described in Table 1. In 14
(24%) patients, the second test was performed after
discharge from the ICU. Six patients had in both
tests Δ cortisol <250 nM, and 11 patients recovered
Table 1 Patient characteristics at admission
n = 59
Age 68 (19–87)
Sex (m/f) 35 (59)/24(41)
Admission diagnosis
Trauma and postoperative 23 (39)
Respiratory insufficiency 16 (27)
CPR 5 (9)
Sepsis 10 (17)
Renal insufficiency 4 (7)
Other 11 (19)
Median (range) or number (%) where appropriate. Patients may have more
than two admission diagnoses. CPR, cardiopulmonary resuscitation.
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four patients had a normal response in both tests. All pa-
tients received hydrocortisone after the first test awaiting
results.
ACTH and cortisol
Levels of Δ cortisol as a continuous variable, which were
directly associated with Δ free cortisol (P < 0.001), were
inversely associated with ACTH levels irrespective of
time (P < 0.001). Similarly, baseline cortisol and cortisol/
ACTH were inversely and directly associated with Δ
cortisol (P = 0.042 and 0.004), respectively. Test character-
istics according to Δ cortisol <, ≥250 nM on test days are
described in Table 2. It shows that the response in Δ (free)
cortisol to exogenous ACTH was low when baseline
ACTH as well as (free) cortisol levels were relatively high,
but baseline (free) cortisol to ACTH ratios were low, as
compared with normal responders to exogenous ACTH.Table 2 ACTH Test 1 and 2 classified according to groups of Δ
Test 1 Δ <250 nM Test 1 Δ ≥250
n = 17 n = 42
ACTH, pM 3.1 (1.1-18.0) 1.5 (1.1-15.0)
Baseline cortisol, nM 470 (200–1,355) 430 (75–2,670)
Baseline cortisol/ACTH, nM/pM 148 (36–250) 238 (14–2,054)
Baseline free cortisol, nM 77 (63–357) (n = 9) 86 (38–256) (n =
Baseline free cortisol/ACTH, nM/pM 22 (9–38) 39 (16–89)
Δ cortisol, nM 140 (−50-245) 388 (260–4,015
Δ free cortisol, nM 59 (−71-124) 151 (74–678)
CBG, mg/L 23 (6–43) 29 (13–63)
Albumin, g/L 13 (6–32) 17 (6–24)
Days from admission to test 1 (0–50) 3 (0–44)
Days between tests n.a. n.a.
Days after stopping hydrocortisone n.a. n.a.
Median (range); ACTH, adrenocorticotropic hormone; CBG, cortisol-binding globulin. aMaCBG increased but ACTH and (free) cortisol did not de-
crease in time, in spite of decreasing indices of disease se-
verity (Table 3).
Clinical correlates
The following inversely related to Δ cortisol as a con-
tinuous variable (in GEE), independent of time: APA-
CHE II (P < 0.001), renal replacement therapy (P = 0.047),
sepsis (P = 0.055), positive cultures (0.041), and the aPTT
(P = 0.020). In multiple GEE, a low Δ cortisol response
was associated with sepsis (P = 0.003) and a low cortisol/
ACTH ratio (P = 0.008) and their first-order interaction
(P = 0.003). Clinical variables for Δ cortisol <, ≥250 nM on
test days are described in Table 3. Low responders had ele-
vated APACHE II scores and tended more often to have
SIRS and sepsis, even though decreasing in time, than did
normal responders. The aPTT was higher in the first test
and the platelets in the second test in low versus normal
responders (interaction between Δ cortisol and time). No
differences in ICU or hospital mortality were found
among response groups, nor in groups with persistently
low or normal responses or changing from a low to nor-
mal response or vice versa.
Correlations
Baseline total and free cortisol directly correlated at
rs = 0.78, P < 0.001; total and free Δ cortisol also cor-
related (rs = 0.88; P < 0.001). At baseline, ACTH directly
related to total and free cortisol (rs = 0.34; P = 0.001 and
rs = 0.52; P = 0.001, respectively). Baseline ACTH in-
versely related to Δ total and free cortisol (rs = −0.32,
P = 0.002 and rs = −0.49, P = 0.001, respectively). Base-
line (free) cortisol inversely related to Δ (free) cortisol: min
rs = −0.26, p = 0.005 and max rs = −0.45, P = 0.001. Baselinecortisol <, ≥ 250 nM
nM Test 2 Δ <250 nM Test 2 Δ ≥250 nM P Δ cortisol,
time, interactionn = 14 n = 45
6.0 (1.1-14.0) 3.8 (1.0-8.9) 0.001, 0.025, 0.72
655 (335–1,890) 495 (35–2,670) 0.021, 0.12, 0.30
109 (48–1,718) 126 (35–2,054) 0.029, 0.16, 0.14
14) 154 (114–252) (n = 6) 75 (4–151) (n = 20) 0.001, 0.91, 0.19
26 (11–43) 17 (4–35) 0.042, 0.10, <0.001
) 177 (−80-230) 425 (255–965) n.a., 0.45, 0.093
40 (−34-99) 133 (32–233) <0.001, 0.15, 0.16
39 (4–60) 41 (21–65) 0.060, <0.001, 0.90
16 (12–28) 20 (8–32) 0.25, <0.001, 0.89
25 (9–49)
18 (8–34) 16 (8–43)
7 (5–12) 7 (5–14) 0.75a
nn-Whitney U test, otherwise generalized estimating equations; n.a., not applicable.
Table 3 Clinical variables according to Δ cortisol <, ≥ 250 nM
Test 1 Δ < 250 nM Test 1 Δ ≥250 nM Test 2 Δ <250 nM Test 2 Δ ≥250 nM P Δ cortisol,
time, interactionn = 17 n = 42 n = 14 n = 45
Disease severity
APACHE II 19 (14–33) 17 (5–31) 16 (10–24) 14 (5–21) 0.002, <0.001, 0.90
SOFA 9 (2–16) 9 (2–16) 5 (0–10) 4 (0–16) 0.46, <0.001, 0.91
MAP, mm Hg 71 (53–102) 80 (36–114) 83 (65–102) 87 (50–127) 0.20, 0.002, 0.61
Vasopressors/inotropes 13 (76) 35 (83) 4 (29) 9 (20) 0.85, <0.001, 0.56
MV 16 (94) 40 (95) 11 (79) 28 (62) 0.81, 0.002, 0.43
Renal replacement therapy 3 (17) 9 (20) 4 (29) 5 (11) 0.19, 0.88, 0.10
Infection
Temperature, °C 36.8 (31.0-40.1) 36.9 (31.6-38.3) 37.1 (35.4-37.6) 36.8 (35.3-38.6) 1.0, 0.44, 0.83
Leukocytes, ×109/L 13.4 (2.4-71.9) 13.3 (2.2-36.0) 12.7 (5.4-89.7) 9.9 (2.7-32.2) 0.35, 0.12, 0.82
SIRS 16 (94) 34 (81) 10 (71) 23 (51) 0.066, 0.002, 0.79
Sepsis 11 (65) 19 (45) 4 (29) 6 (13) 0.055, 0.001, 0.89
Positive cultures 11 (65) 20 (48) 4 (29) 8 (18) 0.15, 0.002, 0.88
Coagulation
Platelets, ×109/L 204 (59–661) 185 (51–803) 235 (24–419) 281 (88–721) 0.084, 0.19, 0.016
PT, INR 1.53 (0.99-2.47) 1.47 (1.05-4.77) 1.17 (0.98-5.46) 1.20 (1.02-3.04) 0.81, 0.068, 0.99
aPTT, seconds 60 (35–92) 48 (31–77) 55 (38–72) 51 (31–103) 0.14, 0.94, 0.037
Outcome
Length of ICU stay, days 41 (11–130) 30 (3–104) 36 (13–92) 30 (3–130) 0.93a, 0.70a
Length of hospital stay, days 60 (21–230) 51 (15–141) 58 (31–230) 54 (15–175) 0.51a, 0.70a
ICU mortality 5 (29) 6 (14) 2 (14) 9 (20) 0.27b,1.00b
Hospital mortality 7 (41) 14 (33) 5 (36) 16 (36) 0.57b,1.00b
Median (range) or number (%), where appropriate; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; MAP: mean
arterial pressure; MV, mechanical ventilation; SIRS, systemic inflammatory response syndrome; PT, prothrombin time; INR, international normalized ratio; aPTT: activated
partial thromboplastin time; ICU, intensive care unit. aMann-Whitney U test, bFisher Exact test, otherwise generalized estimating equations.
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sol (rs = 0.25, P = 0.015 to rs = 0.53, P < 0.001; Figure 2).
Total and free cortisol/ACTH ratios directly correlated at
rs = 0.82, P < 0.001.
Predictive values
Baseline ACTH and cortisol/ACTH predicted a low
cortisol response to exogenous ACTH (AUROC, 0.72,
P = 0.001, and 0.66, P = 0.017, respectively).
Discussion
Our study suggests that, particularly in sepsis, dimin-
ished adrenal sensitivity to endogenous ACTH is associ-
ated with a low cortisol response to exogenous ACTH,
irrespective of cortisol protein binding and stage of crit-
ical illness. This may denote adrenal dysfunction and in-
sufficiency, relative to severity of disease.
Some studies suggest that baseline total cortisol is
more elevated in patients subsequently responding less
to exogenous ACTH with severe illness and elevated risk
for death, than in those with normal baseline levels andresponses [1,3,4,7,8,10,15,27]. In studies not reporting
this relation, decreased binding molecules may have at-
tenuated total cortisol levels [3,5-7,13,14]. Our study also
suggests increasing baseline and decreasing Δ cortisol
with increasing disease severity (APACHE II scores), so
that adrenal function may not be well adapted to disease
severity, thus suggesting insufficiency. Some studies eval-
uated baseline endogenous ACTH or cortisol/ACTH ra-
tios and found relatively increased values and decreased
ratios, respectively, at least in the acute phase of critical
illness and predicting mortality [3,4,16-18]. Our ACTH
levels are in the low-normal range, as reported before
[6], but, nevertheless, predicted a low response to ex-
ogenous ACTH, irrespective of stage of disease. The lat-
ter, otherwise, renders unlikely a confounding effect of
intercurrent hydrocortisone treatment. This is the first
report, to the best of our knowledge, suggesting adrenal
dysfunction on the basis of diminished adrenal sensitivity
to endogenous and exogenous ACTH, as described after
etomidate administration [16,19]. The time dependency of
the association between a low free cortisol/ACTH ratio
Figure 2 The cortisol-to-ACTH ratio at baseline and the subsequent response in increase in circulating total (A) and free (B) cortisol
with exogenous ACTH: rs = 0.25 (r
2 = 0.06), P = 0.015; rs = 0.53 (r
2 = 0.28), P < 0.001, respectively, together for Tests 1 and 2 in the
course of critical illness (see text; no differences between tests). This suggests that ACTH-insensitive adrenals respond less with cortisol
secretion to exogenous ACTH.
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tributed in part to the low number of observations avail-
able on free cortisol in low responders of Test 2. In any
case, our results again suggest that (changes in) free corti-
sol parallel (changes in) total cortisol with ACTH testing,
in spite of changing binding proteins in time [17]. Hence,
free and total cortisol were almost interchangeable in the
current evaluation.
Particularly during the chronic or prolonged phase of
critical illness (rather than in the acute phase, as in the
Boonen et al. study [20]), low ACTH and elevated corti-
sol levels can be seen, suggestive of increased sensitivity
to ACTH or ACTH-independent cortisol production
[2,21-23]. The latter may be caused by non-ACTHpituitary stimulants or feedback suppression of ACTH
after impaired cortisol metabolism and persistent hyper-
cortisolemia [2,21-23]. Our results do not suggest rever-
sal or development of this so-called cortisol-ACTH
dissociation, because the cortisol/ACTH ratio did not
change in time. Boonen et al. [21] suggested that baseline
cortisol was not under control of subnormal ACTH
levels and that exogenous ACTH resulted in low re-
sponses of circulating cortisol, even though only peak
and not Δs cortisol were reported. This was attributed, at
least in part, to impaired cortisol metabolism with dimin-
ished feedback ACTH secretion.
However, lower endogenous ACTH levels in the
course of panhypopituitarism or steroid treatment, for
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ous ACTH only after days to weeks [2,29]. In contrast,
our correlation data suggest basal and particularly free
cortisol levels being under persistent control of ACTH,
as reported before [4,18]. Our results refute the impaired
metabolism-low endogenous ACTH hypothesis in either
the acute or the chronic phase of critical illness to ex-
plain fully a low Δ cortisol with exogenous ACTH, by
suggesting that relatively low responses to exogenous
ACTH are associated with diminished adrenal sensitivity
to endogenous ACTH, irrespective of stage of disease.
Nevertheless, the discrepancy between our study and the
Boonen et al. study [19] is hard to explain, unless their
ACTH values were diluted by more extensive fluid ther-
apy or taken at different stages of disease than in our
study.
Even though disease severity diminished in time in this
selected cohort, the number of patients with subnormal
ACTH responses only slightly decreased and tended to
relate to persistent or new occurrence of SIRS and
culture-positive sepsis and coagulation disturbances
(prolonged aPTT), in line with other investigators sug-
gesting sepsis as the main risk factor for adrenal dys-
function of the critically ill [3,6,7,9-14,18,26-28]. The
currently prospectively studied clinical risk factors in
time closely agree with those retrospectively found by us
before, even in longitudinal analysis [8,15]. This favors
the idea that a low Δ cortisol in time is of clinical signifi-
cance, rather than reflecting poor reproducibility of the
ACTH test.
Adrenal injury after adrenal thrombosis or hemorrhage
may underlie the association of dysfunction with coagula-
tion disturbances (for aPTT with Δ cortisol as a continu-
ous variable), as described in meningococcemia and the
Waterhouse-Friderichsen syndrome, because other infec-
tions may also cause adrenal thrombosis, hemorrhage, and
insufficiency [2,16,24,25]. Heparin treatment also is a well-
known risk factor [24].
The observed endocrine results did not bear any rela-
tion to mortality in the current study (as opposed to
previous ones [1,3,7,8,10,12,13,15,27]), which may be
explained by patient selection of acute-phase survivors
allowing repeated ACTH testing within 3 weeks, on the
average, by virtue of study design. Together with the ex-
clusion of etomidate-treated patients, this selection may
also explain the relatively low frequency of adrenal dys-
function of about 30% in our patients, whereas adrenal
insufficiency may occur in up to 60% of those with sep-
tic shock [6-8,10-12,14,15,18,27]. Finally, we did not
know or evaluate the potentially interfering phenomenon
of steroid resistance in critical illness [30].
Our study has several limitations. First, we did not
routinely measure cortisol metabolism or tissue effects
in our patients because this requires elaborate techniques[8]. The patients studied are a selection because we wanted
to evaluate repeated ACTH tests in various stages of
disease.
Conclusions
Our data in a large cohort of critically ill patients with
follow-up ACTH testing suggest that, even though the
HPA axis is activated during critical illness and recovery
from the acute phase, diminished adrenal ACTH sensi-
tivity predicts a low increase of cortisol to exogenous
ACTH, suggesting adrenal dysfunction irrespective of
stage of disease. The data further suggest a role of disease
severity and culture-positive sepsis. The implications for
treatment by corticosteroids remain unanswered by our
study. Our study may nevertheless imply imaging the ad-
renals to look for hemorrhage or thrombosis in future
studies on sepsis-induced adrenal dysfunction to help in
deciding on corticosteroids.
Key messages
 Even though the pituitary-adrenal axis is activated
after stress in the course of critical illness, diminished
adrenal sensitivity for endogenous ACTH is associated
with a low increase of cortisol to exogenous ACTH.
 Diminished adrenal sensitivity to endogenous and
exogenous ACTH suggests adrenal dysfunction.
 The data further suggest a role of disease severity
and culture-positive sepsis in the adrenal dysfunction
and insufficiency of the critically ill.
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